**Core Concept**
The underlying principle being tested is the use of serologic markers in monitoring the course of **germ cell tumors**, specifically **yolk sac carcinoma**, a type of ovarian cancer. **Alpha-fetoprotein (AFP)** is a key protein in this context.

**Why the Correct Answer is Right**
Yolk sac carcinoma is known to produce **AFP**, making it a reliable tumor marker for this disease. Elevated levels of **AFP** can indicate the presence of yolk sac carcinoma, and monitoring these levels after surgery can help assess the effectiveness of treatment and detect potential recurrence.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because it is not specifically associated with yolk sac carcinoma.
**Option B:** Incorrect as it is more commonly associated with other types of cancers.
**Option C:** Incorrect because, although it can be elevated in various cancers, it is not the most specific marker for yolk sac carcinoma.
**Option D:** This option is not provided, but typically, other tumor markers are less specific for yolk sac carcinoma than **AFP**.

**Clinical Pearl / High-Yield Fact**
Remember, **AFP** is a critical marker for yolk sac carcinoma, and its levels should be monitored closely in patients with this diagnosis. This is particularly important for assessing treatment response and detecting early signs of recurrence.

**Correct Answer:** D. Alpha-fetoprotein (AFP)